George Kemble, Director at Sagimet Biosciences Inc. (SGMT), sold 350,987 shares at $10.23 ($3.6M) on 2026-08-14, disclosed to the SEC on 2026-08-17.
Scheduled sale ($3.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SGMT | SELL | 2025-11-21 | $580K | — | Filing → |
| SGMT | SELL | 2024-07-25 | $150K | — | Filing → |
| SGMT | SELL | 2024-07-23 | $44K | — | Filing → |